Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Senescent cells, formed in response to physiological and oncogenic stresses, facilitate protection from tumourigenesis and aid in tissue repair. However, accumulation of such cells in tissues contributes to age-related pathologies. Resistance of senescent cells to apoptotic stimuli may contribute to their accumulation, yet the molecular mechanisms allowing their prolonged viability are poorly characterized. Here we show that senescent cells upregulate the anti-apoptotic proteins BCL-W and BCL-XL. Joint inhibition of BCL-W and BCL-XL by siRNAs or the small-molecule ABT-737 specifically induces apoptosis in senescent cells. Notably, treatment of mice with ABT-737 efficiently eliminates senescent cells induced by DNA damage in the lungs as well as senescent cells formed in the epidermis by activation of p53 through transgenic p14 ARF . Elimination of senescent cells from the epidermis leads to an increase in hair-follicle stem cell proliferation. The finding that senescent cells can be eliminated pharmacologically paves the way to new strategies for the treatment of age-related pathologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another reported hallmark of senescent fibroblasts, in idiopathic pulmonary fibrosis, is the enhanced expression of anti-apoptotic BCL2 family proteins such as BCL2L2, BCL2 and BCL2L1 along with reduced levels of the pro-apoptotic proteins BAK1 and BAX180,181.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [181]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Because both SCs and platelets, but not NCs, are primarily dependent on Bcl-xl for survival16–18,24–27 (Supplementary Fig. 1h), we evaluated the effects of PZ compared with ABT263 on the viability of WI38 NCs (Fig. 1g, left panel), IR-SCs (Fig. 1g, middle panel), and platelets (Fig. 1g, right panel).”
From Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity (2020) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Therefore, PZ can selectively induce apoptosis in SCs, but not platelets, which are dependent on Bcl-xl for survival while having minimal toxicity to NCs that are less sensitive to Bcl-xl inhibition than SCs16–18,24–27.”
From Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity (2020) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, inhibition of Bcl-2 and/or Bcl-w can potentiate the cytotoxicity of Bcl-xl inhibition against SCs as seen in previous studies with the dual Bcl-2/w and Bcl-xl inhibitors ABT737 and ABT263 (refs. 16,17).”
From Using proteolysis-targeting chimera technology to reduce navitoclax platelet toxicity and improve its senolytic activity (2020) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For this, senescent cells rely on the upregulation of pro-survival pathways (e.g., BCL-2 and Ephrins) that actively inhibit apoptosis [3,14,15].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [15]
Experimental — accuracy not yet measured
26 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 1×
“To examine the resistance of senescent cells to intrinsic and extrinsic apoptotic pathways, we induced senescence in normal primary human fibroblasts (IMR-90), one of the most widely used cell models for the study of this program 5,22,23 .”
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 1×
“Likewise, we observed no difference in protein levels following inhibition of the proteasome machinery; this is in contrast to the dramatic increase observed in levels of TP53 (p53) protein, which is known to be regulated by the proteasome 28 (Supplementary Fig.”
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 2×
“Overall, these findings suggest that the clearance of senescent cells can lead to tissue renewal and improved fitness, a possibility consistent with the recent finding that elimination of senescent cells via transgenic techniques and combinatorial treatments improves aging-associated phenotypes 14,43 .”
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Souers, A. J., Leverson, J. D., Boghaert, E. R., Ackler, S. L., Catron, N. D., Chen, J., Dayton, B. D., Ding, H., Enschede, S. H., Fairbrother, W. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3048 · Cited by 3,058
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954 · cited 3×
“However, if senescent cells are retained in tissues, these factors can promote local inflammation, tissue aging, tissue destruction and, potentially, tumourigenesis and metastasis in a cell non-autonomous manner 1,3,12,13 .”
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Cited by
Items 701–800 of 1,000
Gang, D., Jiang, Y., Wang, X., Zhou, J., Zhang, X., He, X., Dong, R., Huang, Z., & Jiang, S. (2023) · Clinical & Translational Oncology · doi:10.1007/s12094-023-03168-8 · Cited by 6
Calvo, L., Cheng, S., Skulimowski, M., Clément, I., Portelance, L., Zhan, Y., Carmona, E., Lafontaine, J., de Ladurantaye, M., Rahimi, K., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/425199 · Cited by 7
A Multidimensional Systems Biology Analysis of Cellular Senescence in Ageing and DiseasePreprint
Avelar, R. A., Ortega, J. G., Tăcutu, R., Tyler, E. J., Bennett, D. F., Binetti, P., Budovsky, A., Chatsirisupachai, K., Johnson, E., Murray, A., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/743781 · Cited by 6
Emerging strategies in senotherapeutics: from broad-spectrum senolysis to precision reprogramming
Zhang, W., Song, S., Zhang, Y., Pan, Y., Hu, D., & Wang, Y. (2026) · npj Aging · doi:10.1038/s41514-026-00355-z · Cited by 6
Lafargue, A. M., Wang, H., Chettiar, S. T., Gajula, R. P., Shetty, A. C., Song, Y., Simons, B. W., Khan, M. A., Nguyen, T., Tseng, H. W., et al. (2025) · Neoplasia · doi:10.1016/j.neo.2025.101179 · Cited by 6
Cellular senescence in colorectal cancer: its occurrence, effect and therapy
Liang, Y., Wang, M., Wang, X., Yang, Z., Wang, S., Li, F., Su, L., & Yang, L. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1580951 · Cited by 6
Shahzaib, M., Aprile, D., Squillaro, T., Alessio, N., Peluso, G., Bernardo, G. D., & Galderisi, U. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102916 · Cited by 7
The drug discovery and therapeutic nano-strategies targeting cellular senescence
Wang, Y., Liu, M., Chen, X., Wang, S., Li, J., Sun, Y., Zheng, X., Zhang, J.-X., & Li, H. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102480 · Cited by 13
Senotherapeutics in Malignant Brain Cancer Therapy
Kaina, B., & Christmann, M. (2025) · Current Oncology Reports · doi:10.1007/s11912-025-01733-8 · Cited by 5
Hamburger, E. C. B., Brigato, P., Rosenzweig, D. H., & Haglund, L. (2026) · BMC Cancer · doi:10.1186/s12885-026-15650-x · Cited by 6
Cellular senescence as a source of chronic microinflammation that promotes the aging process
Nakanishi, M. (2025) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.101.014 · Cited by 5
In vitro senescence and senolytic functional assays
Ryan, P., & Lee, J. (2025) · Biomaterials Science · doi:10.1039/d4bm01684j · Cited by 7
Shatrova, A. N., Domnina, A. P., Pugovkina, N. A., Lp, A., & Marakhova, I. I. (2023) · Biomedicines · doi:10.3390/biomedicines11020301 · Cited by 5
SATB1, senescence and senescence‐related diseases
Qi, W., Bai, J., Wang, R., Zeng, X., & Zhang, L. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31327 · Cited by 6
Targeting CK2 eliminates senescent cells and prolongs lifespan in Zmpste24-deficient mice
Zhang, J., Sun, P., Wu, Z., Wu, J., Jia, J., Zou, H., Mo, Y., Zhou, Z., Liu, B., Ao, Y., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06760-0 · Cited by 6
Senolysis and Senostasis Through the Plasma Membrane
Kim, K. M., Noh, J. H., & Gorospe, M. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_7 · Cited by 7
Multiple characteristic alterations and available therapeutic strategies of cellular senescence
Zhao, Y., Li, H., Guo, Q., & Hui, H. (2023) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200178 · Cited by 5
Pan, Z., Yin, H. R., Wang, S., Xiong, G., & Yin, Z. (2020) · Engineering in Life Sciences · doi:10.1002/elsc.202000039 · Cited by 4
Targeting Alternative Splicing for Reversal of Cellular Senescence in the Context of Aesthetic Aging
Bramwell, L. R., & Harries, L. W. (2020) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000007618 · Cited by 6
Synephrine Inhibits Oxidative Stress and H2O2-Induced Premature Senescence
Abe, H., Indo, H. P., Ito, H., Majima, H. J., & Tanaka, T. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01669-7 · Cited by 4
Next-gen senotherapeutics: AI/ML-driven strategies for aging and age-related disorders
Javali, P. S., Kumar, A., Sarkar, S., Varshini, R. S., Mathew, D. J., & Thirumurugan, K. (2025) · Advances in pharmacology · doi:10.1016/bs.apha.2025.01.017 · Cited by 4
Li, J., Zhao, K., Yang, G., Lv, H., Zhang, R., Li, S., Chen, Z., Xu, M., Yang, N., & Dai, S. (2025) · Molecules · doi:10.3390/molecules30122653 · Cited by 5
Otsuka, T., & Matsui, H. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112087 · Cited by 8
Decoding senescent drivers in Alzheimer's disease: From bench to bedside
Zhou, R., Lin, X., Liao, Z., Lin, J., Zheng, R., Ni, H., Liu, W., Feng, Z., He, Q., Lin, X., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102978 · Cited by 4
DEL‐1 is an Endogenous Senolytic Protein that Inhibits Senescence‐Associated Bone Loss
Lim, J., Sirisereephap, K., Wang, H., Trimaglio, G., Chung, K., Korostoff, J. M., Kajikawa, T., Li, X., Surboyo, M. D. C., Maekawa, T., et al. (2026) · Advanced Science · doi:10.1002/advs.202509263 · Cited by 5
Sobeai, H. M. A., Alanazi, A. M., Alotaibi, F., Alhoshani, A., Alhazzani, K., Almutairi, M. M., Almudimeegh, S., al-Ramadi, B. K., Chakraborty, E., Saleh, T. M., et al. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1661424 · Cited by 5
Chronic Kidney Disease and Cellular Senescence
Morevati, M., Tavenier, J., Scheibye‐Knudsen, M., Houlind, M. B., Hedayati, A., & Hornum, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27073205 · Cited by 6
Inflammaging: Experimental Insights and Translational Advances
Cossarizza, A. (2026) · European Journal of Immunology · doi:10.1002/eji.70239 · Cited by 8
A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research
Elshazly, A. M., Shahin, U., Shboul, S. A., Gewirtz, D. A., & Saleh, T. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.124.000871 · Cited by 4
Senolytic Interventions for Type 2 Diabetes: Current Evidence and Future Directions
Sodini, S., & Suárez‐Ortegón, M. F. (2025) · Diabetology · doi:10.3390/diabetology6060048 · Cited by 6
Aging and anti-aging strategies: A review of past and future therapeutics
Wei, Y., Xiong, B., Song, Z., Zhong, S., Zheng, N., Zhang, A., Chen, Y., & Sun, H. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118340 · Cited by 4
Poddar, S. K., Yang, Y., Pal, P., Jin, Z., Pei, J., Xiao, Y., Hu, W., Zhang, P., Adekunbi, P., Thummuri, D., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01834 · Cited by 5
Cellular senescence: mechanisms and clinical implications
Михайловна, М. А., Pashenkov, M. V., & Pinegin, B. V. (2024) · Immunologiya · doi:10.33029/1816-2134-2024-45-2-221-234 · Cited by 10
Xie, J., Shu, X., Xie, Z., Tang, J., & Guo, W. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177475 · Cited by 5
Natural Product-Derived Senotherapeutics: Extraction and Biological Evaluation Techniques
Pratsinis, H., Mavrogonatou, E., Zervou, S., Triantis, T. M., Hiskia, A. E., & Kletsas, D. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4426-3_19 · Cited by 4
Santos‐Sousa, D., da Rosa, S., & Filippi‐Chiela, E. C. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112052 · Cited by 9
Proteolysis targeting chimeras as senolytics: An emerging senotherapy for combating aging
Cruickshank-Taylor, A. B., Kozora, J. S., Carew, J. S., Nawrocki, S. T., & Wang, W. (2025) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103752 · Cited by 4
Recent advances in radiobiology with respect to pleiotropic aspects of tissue reaction
Suzuki, K., Amrenova, A., & Mitsutake, N. (2020) · Journal of Radiation Research · doi:10.1093/jrr/rraa086 · Cited by 5
Molecular mechanisms of cellular senescence
Nehme, J., Varela-Eirín, M., & Demaria, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823318-4.00034-2 · Cited by 4
Xia, Y., Li, J., Wang, L., Xie, Y., Zhang, L., Han, X., Tan, W., & Liu, Y. (2022) · Angewandte Chemie · doi:10.1002/ange.202214169 · Cited by 4
Yamaguchi, M., Kajiya, H., Egashira, R., Yasunaga, M., 萩尾, 佳., Sato, A., Toshimitsu, T., Naito, T., & Ohno, J. (2018) · Journal of Hard Tissue Biology · doi:10.2485/jhtb.27.199 · Cited by 5
Senescent cells and the dynamics of agingPreprint
Karin, O., Agrawal, A., Porat, Z., Krizhanovsky, V., & Alon, U. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/470500 · Cited by 4
Self-citationA ganglioside-based senescence-associated immune checkpointPreprint
Iltis, C., Seguin, L., Cervera, L., Duret, L. C., Hamidouche, T., Kunz, S., Croce, O., Delannoy, C. P., Guérardel, Y., Allain, F., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.23.440408 · Cited by 4
The brain-bone marrow axis and its implications for chronic traumatic brain injuryPreprint
Ritzel, R. M., Li, Y., Jiao, Y., Doran, S. J., Khan, N., Henry, R. J., Brunner, K., Loane, D. J., Faden, A. I., Szeto, G. L., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3356007/v2 · Cited by 4
Senotherapeutics: Milestones, innovations, and future prospects
Atasever, E., Atayik, M. C., & Çakatay, U. (2025) · Advances in pharmacology · doi:10.1016/bs.apha.2025.01.021 · Cited by 6
Cellular Senescence in Cancer: Mechanisms, Roles in Tumor Progression, and Therapeutic Implications
Yan, J., Zhang, Y., Mao, G., Yu, J., Zhou, T., & Hao, J. (2025) · MedComm – Oncology · doi:10.1002/mog2.70029 · Cited by 3
Growth Differentiation Factor 11 Attenuates Photoaging through Ferroptosis Pathway in SZ95 Sebocytes
Liu, Y., Zeng, J., Liu, X., Qin, Y., Zhang, Y., Zouboulis, C. C., & Xiao, Z. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.07.015 · Cited by 4
Non-oncologic to oncologic drug: A systematic review of drug repurposing in cancer
Dhanush, Y., & Ganesh, V. S. (2025) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-025-04822-4 · Cited by 5
Targeting persister cells: proactively overcoming therapy resistance in aggressive B cell lymphomas
Tao, J., Qiu, K., & Williams, M. E. (2026) · Trends in cancer · doi:10.1016/j.trecan.2025.12.007 · Cited by 3
Feng, Y. R., Zhi, X., Xiao, T., & Feng, L. (2026) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2026.112158 · Cited by 6
Sreeram, I., Plans-Marin, S., Cruz‐Rodríguez, M., Aliagas, E., Palau-Gallinat, D., Muñoz‐Pinedo, C., & Nadal, E. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08696-z · Cited by 4
Qiao, Y., Zhao, J., Liu, M., Liu, J., Qiao, Z., Xu, R., Ning, X., Sun, S., & Chen, X. (2026) · Biomolecules · doi:10.3390/biom16040611 · Cited by 3
Exploiting senescence as a therapeutic target in osteoarthritis
Larbie, C., & Raza, U. (2024) · Asia-Pacific Journal of Pharmacotherapy & Toxicology · doi:10.32948/ajpt.2024.11.19 · Cited by 4
New Relevant Evidence in Cholangiocarcinoma Biology and Characterization
Porro, N., Spínola-Lasso, E., Pastore, M., Caligiuri, A., Tommaso, L. D., Marra, F., & Gentilini, A. (2024) · Cancers · doi:10.3390/cancers16244239 · Cited by 4
Liu, J., Li, H., Sun, R., Ying, G., & Liang, Z. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03818-7 · Cited by 4
Consequences of senotherapies for tissue repair and reprogramming
van Vliet, T., Kohli, J. S., & Demaria, M. (2019) · Translational Medicine of Aging · doi:10.1016/j.tma.2019.01.003 · Cited by 4
Standard of care drugs do not modulate activity of senescent primary human lung fibroblasts
Badaro‐Garcia, S., Hohmann, M. S., Coelho, A. L., Verri, W. A., Jr., & Hogaboam, C. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-30844-0 · Cited by 4
Interplay of autophagy, apoptosis, and senescence in primary biliary cholangitis
Kouroumalis, E., Tsomidis, I., & Voumvouraki, A. (2023) · Exploration of Digestive Diseases · doi:10.37349/edd.2023.00028 · Cited by 3
Senescence detection using reflected light
Dedic, B., Westerberg, L. J. S., Solís, A. M., Dumont, K. D., Ruas, J. L., Thorell, A., Näslund, E. B., & Spalding, K. L. (2024) · Aging Cell · doi:10.1111/acel.14295 · Cited by 2
Gomez, L. S., & Jurk, D. (2024) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-66768-8_5 · Cited by 4
Gerosuppressive and Senolytic Nutrients
Nehlin, J. O. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-83017-5_22 · Cited by 3
Wu, G., Li, X., Zhan, Y., Fan, X., Xu, L., Chen, T., & Wang, X. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.08.023 · Cited by 3
Sequence and expression regulation of the BCL2L2 gene in pigs
Zhang, D., Du, F.-F., Jing, X.-Y., Wang, L., Liu, D., & Yang, X. (2022) · Gene · doi:10.1016/j.gene.2022.146992 · Cited by 4
Picallos-Rabina, P., Silva‐Álvarez, S. D., Antelo-Iglesias, L., Triana-Martínez, F., & Collado, M. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_5 · Cited by 3
Lee, S.-M., Seo, E., Kim, Y.-H., & Min, J. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2025.119907 · Cited by 2
PKM2+ apoptotic vesicle-mediated systemic senolytics ameliorate chronic periodontitis
Meng, H., Yan, X., Jiang, Y., Li, W., Cao, Z., Zhang, M., Li, P., Li, C., & Shi, S. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.06.041 · Cited by 7
Guo, X., Zhang, S., Sun, Q., Li, H., & Wang, L. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1627412 · Cited by 4
Guan, Y., Bai, X., Li, C., Zhang, Z., He, Q., Chen, L., Xie, Y., & Wang, Z. (2025) · Genes & Diseases · doi:10.1016/j.gendis.2025.101871 · Cited by 6
Vardon, A., Haston, S., Hamdi, H., Cooksley, G., Guiho, R., Carvalho, D. M., Carter, R., Boult, J. K. R., Gharai, D., Cloete, I., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-32676-6 · Cited by 4
β-Galactosidase-Cleavable Polymeric Senotherapeutics for Protein-Binding Photodynamic Senolysis
Ali, N., Huang, W., Tian, J. H., & Zhang, W. (2025) · ACS Macro Letters · doi:10.1021/acsmacrolett.5c00612 · Cited by 3
Llop‐Hernández, À., Verdura, S., López, J., Martín-Castillo, B., Menéndez, J. A., & Cuyàs, E. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-02967-6 · Cited by 4
Epigenetic dynamics of cellular senescence: From mechanistic insights to precision senotherapy
Hu, X., Lai, W., Liu, M., & Wang, B. (2026) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004042 · Cited by 2
Mansour, D. A., Hassan, A. A., & Baraka, S. M. (2026) · Tissue and Cell · doi:10.1016/j.tice.2026.103559 · Cited by 6
Hartono, M., Ge, J., Denholm, M., Ellis, M. G., Henríquez, J. A., Baker, A., Rintoul, R. C., Euser, T. G., Fruk, L., & Muñoz‐Espín, D. (2026) · Nature Aging · doi:10.1038/s43587-026-01116-z · Cited by 2
Characterization of the m 6 A Epitranscriptome in Fibroblast Senescence
Abdelmohsen, K., Banskota, N., Rossi, M., Pal, A., Baranzini, M., Prampolini, C., Arends, E. M., De, S., & Gorospe, M. (2026) · Molecular and Cellular Biology · doi:10.1080/10985549.2026.2674080 · Cited by 2
Molecular mechanisms and recent advances in cellular senescence
Hussain, A., Tatar, M., & Gong, R. (2026) · Cell & Bioscience · doi:10.1186/s13578-026-01596-x · Cited by 3
A general model for cell death and biomarker release from injured tissues
Li, J., Karlsson, M. O., Sanhajariya, S., Isbister, G. K., & Duffull, S. B. (2020) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-020-09720-1 · Cited by 2
Zorina, A. I., Zorin, V. L., Kopnin, P., Ustyugov, A. Y., & Manturova, N. E. (2023) · Russian Journal of Clinical Dermatology and Venereology · doi:10.17116/klinderma202322031338 · Cited by 2
Franco, Y. A., de Moraes, M. O., Carvalho, L. A. D. C., Döhle, W., da Silva, R. O., Noma, I. H. Y., Lima, K., Potter, B. V. L., Machado‐Neto, J. A., & Maria–Engler, S. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411314 · Cited by 2
Sun, J.-Y., Zhao, J., Qiu, Y., & Fan, T. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.110898 · Cited by 2
Senescence-Induced Atherosclerosis: The Potency of Senolytic Therapy
Ratih, U. S., & Iswanti, F. C. (2024) · Bioscientia Medicina Journal of Biomedicine and Translational Research · doi:10.37275/bsm.v8i8.1036 · Cited by 2
Piperlongumine regulates genes involved in the skin barrier in epidermal keratinocyte HaCaT cells
Lee, K., Kang, D. G., Kim, D.-W., Do, H.-K., Kim, D., & Kim, W. (2024) · Animal Cells and Systems · doi:10.1080/19768354.2024.2361144 · Cited by 2
Wu, J., Bai, Q., Chen, J., Yang, Z., & Zhu, X. (2024) · Plants · doi:10.3390/plants13152139 · Cited by 3
Lokhov, P. G., Balashova, E. E., Maslov, D. L., Trifonova, O. P., & Archakov, A. I. (2024) · Metabolites · doi:10.3390/metabo14110593 · Cited by 3
Bi, J., Zeng, J., Liu, X., Mo, C., Yao, M., Zhang, J., Yuan, P., Jia, B., & Xu, S. (2024) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2024.102209 · Cited by 2
Senotherapy: Implications for Transplantation
Jaros, M., & Melk, A. (2025) · Transplantation · doi:10.1097/tp.0000000000005291 · Cited by 3
ε-Viniferin Rejuvenates Senescence via RGS16 Regulation: In Vitro Evidence
Park, J. H., Lee, K. S., Lee, K. S., Lee, Y. J., Yoon, J. H., So, B., Kim, D., Kim, M., Kwon, H. W., Byun, Y., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18091254 · Cited by 2
Wong, J., Qudrat, A., Mosabbir, A. A., & Truong, K. (2018) · Springer eBooks · doi:10.1007/978-981-13-1699-9_5 · Cited by 3
Induction and Characterization of Cellular Senescence in Salamanders
Yu, Q., Walters, H., & Yun, M. H. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2659-7_8 · Cited by 2
To Find and Destroy: Identification and Elimination of Senescent Cells
Borodkina, A. V., Deryabin, P. I., Griukova, A., & Nikolsky, N. N. (2018) · Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology · doi:10.1134/s1990747818030030 · Cited by 3
Senolytics Target Senescent Cells and Improve Aging and Age-Related Diseases
Buffard, T., & Ferbeyre, G. (2020) · Healthy ageing and longevity · doi:10.1007/978-3-030-44903-2_4 · Cited by 4
Senomorphic, senolytic, and rejuvenation therapies
Zhu, X. Y., & Lerman, L. O. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823318-4.00025-1 · Cited by 4
Hammer, L., Levin‐Salomon, V., Yaeli-Slonim, N., Weiss, M., Dekel‐Bird, N. P., Olender, T., Porat, Z., Winograd-Katz, S. E., Savidor, A., Levin, Y., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13187 · Cited by 2
Perspectives to Modify and Counter Aging in the Frame of Subtelomere–Telomere Theory of Aging
Libertini, G. (2022) · OBM Geriatrics · doi:10.21926/obm.geriatr.2204208 · Cited by 2
Senescence in Aging, Within the Brain and Other Diseases: Mechanisms and Interventions
Chakrabarti, S. K., & Chattopadhyay, D. (2023) · Exploratory Research and Hypothesis in Medicine · doi:10.14218/erhm.2023.00018 · Cited by 1
Current mechanisms in the pathogenesis of lung fibrosis
Engin, M. M. N., & Özdemır, Ö. (2023) · Trends in Immunotherapy · doi:10.24294/ti.v7.i1.2028 · Cited by 2
Silva, A. O., Bitencourt, T. C., Vargas, J. E., Fraga, L. R., & Filippi‐Chiela, E. C. (2024) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2023-0311 · Cited by 4
Čepelak, I., & Dodig, S. (2019) · Rad Hrvatske akademije znanosti i umjetnosti Medicinske znanosti · doi:10.21857/moxpjhglzm · Cited by 3
Cellular senescence in cancers: relationship between bone marrow cancer and cellular senescence
Sarikhani, M., & Firouzamandi, M. (2022) · Molecular Biology Reports · doi:10.1007/s11033-021-07101-6 · Cited by 2
Monovalent Ions and Stress-Induced Senescence in Human Mesenchymal Endometrial Stem CellsPreprint
Shatrova, A. N., Pugovkina, N. A., Domnina, A. P., Nikolsky, N., & Marakhova, I. I. (2021) · Research Square · doi:10.21203/rs.3.rs-1087662/v1 · Cited by 2
Metadata
- Authors
- Yosef, R., Pilpel, N., Tokarsky-Amiel, R., Biran, A., Ovadya, Y., Cohen, S., Vadai, E., Dassa, L., Shahar, E., Condiotti, R., Ben-Porath, I., & Krizhanovsky, V.
- Affiliations
- Weizmann Institute of Science (IL)
- Hebrew University of Jerusalem (IL)
- Corresponding author
- Krizhanovsky, Valery
- Venue
- Nature Communications
- Published
- 2016-04-06
- Volume
- 7
- Issue
- 1
- Pages
- 11190-11190
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4823827
- OpenAlex
- W2319232270
- Cited by
- 1,032
- References
- 48
- Citations by year
- 2026: 116 · 2025: 112 · 2024: 118 · 2023: 111 · 2022: 122 · 2021: 124 · 2020: 125 · 2019: 77 · 2018: 68 · 2017: 44 · 2016: 15
- FWCI
- 54.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- senescent cells, Bcl-w, Bcl-xL, ABT-737, apoptosis, senolytics, age-related diseases, p53, p14ARF, DNA damage, hair follicle stem cells, epidermis, lung, anti-apoptotic proteins
- MeSH terms
- Animals, Antineoplastic Agents, Biphenyl Compounds, Cell Line, DNA Damage, Epidermis, Fibroblasts, Gene Expression Regulation, Humans, Lung, Male, Mice, Inbred C57BL, Mice, Transgenic, Nitrophenols, Piperazines, Proteins, Sulfonamides, Signal Transduction, Tumor Suppressor Protein p53, Cellular Senescence, Apoptosis, Tumor Suppressor Protein p14ARF, RNA, Small Interfering, Cell Proliferation, Apoptosis Regulatory Proteins, bcl-X Protein, Mice, Primary Cell Culture
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.